The Risks of Nanomedicine and the Precautionary Principle

International Library of Ethics, Law and Technology

Volumn 10, Issue , 2014, Pages 131-145

  Andorno, Roberto ^a   Biller Andorno, Nikola ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bovine Spongiform Encephalopathy; Precautionary Measure; Precautionary Principle; Risk Management Process; Scientific Uncertainty

Indexed keywords

EID: 84924091253     PISSN: 18750044     EISSN: 18750036     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6817-1_9     Document Type: Chapter

References (35)

1. Andorno, R. 2004a. The right not to know: An autonomy based approach. Journal of Medical Ethics 30: 435–440.
2. Andorno, R. 2004b. The precautionary principle: A new legal standard for a technological age. Journal of International Biotechnology Law 1(1): 11–19.
3. Bachmann, A. 2006. Nanobiotechnologie. Eine ethische Auslegeordnung, Bern, EKAH (Eidgnenossische Ethikkommission für die Biotechnologie im Ausserhumanbereich).
4. Balbus, J., R. Denison, K. Florini, and S. Walsh. 2005. Getting nanotechnology right the first time. Issues in Science and Technology, Summer, 65–71. Available online at: http://www.issues.org/issues/21.4/balbus.html.
5. Balbus, J., et al. 2007. Meeting report: Hazard assessment for nanoparticles. Report from an interdisciplinary workshop. Environmental Health Perspectives 115(11): 1654–1659.
6. Bawa, R., and S. Johnson. 2007. The ethical dimensions of nanomedicine. Medical Clinics of North America 91(5): 881–887.
7. Borm, P., et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Particle and Fibre Toxicology 3(11): 1–35. Available online at: http://www.particleandfibret-oxicology.com/content/3/1/11.
8. Capurro, R. 2006. Reflections on the ethical aspects of nanomedicine . At: http://www.capurro.de/nanoethics.html.
9. CCNE (Comité Consultatif National d’Ethique). 2007. Opinion n° 96: Ethical issues raised by nanosciences, nanotechnologies and health, Paris. Available online at: http://www.comite-ethique.fr/opinions.php.
10. Coalition of international NGOs. 2007. Principles for the oversight of nanotechnologies and nanomaterials . Online available at: http://www.etcgroup.org/upload/publication/pdf_file2/651.
11. COMEST (UNESCO’s World Commission on the Ethics of Scientific Knowledge and Technology). 2005. The precautionary principle. Paris: UNESCO.
12. Duffin, R., A. Clouter, D.M. Brown, C.L. Tran, W. MacNee, V. Stone, and K. Donaldson. 2002. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Annals of Occupational Hygiene 46(Suppl. 1): 242–245.
13. ECJ (European Court of Justice). 1998. Case C-180/96, United Kingdom v. Commission of the European Communities, 5 May 1998, ECR 1998, I-2265.
14. EGE (European Group on Ethics in Science and New Technologies). 2007. Opinion on the ethical aspects of nanomedicine (Opinion n° 21). Brussels: European Commission. Available online at: http://ec.europa.eu/european_group_ethics/activities/docs/opinion_21_nano_en.pdf.
15. ETC Group. 2003. From genomes to atoms. The big down. Atomtech: Technologies converging at the nano-scale. Winnipeg: ETC Group. Available online at: http://www.etcgroup.org/upload/publication/171/01/thebigdown.pdf.
16. ETC Group. 2006. Nanotech Rx – Medical applications of nano-scale technologies: What impact on marginalized communities? Ottawa: ETC Group. Available online at: http://www.etcgroup. org/en/materials/publications.html?pub_id=593.
17. European Commission. 2000. Communication on the precautionary principle, 2 February 2000.
18. European Council. 2000. Resolution on the precautionary principle. Annex III to the Presidency Conclusions of the Nice European Council Meeting, 7–9 December 2000.
19. Faunce, T., and K. Shats. 2007. Researching safety and cost-effectiveness in the life cycle of nanomedicine. Journal of Law and Medicine 15: 128–134.
20. Freitas, Jr. R.A. 1999. Nanomedicine. Volume I: Basic capabilities. Georgetown: Landes Bioscience. Available online at: http://www.nanomedicine.com/NMI.htm.
21. Gordijn, B. 2007. Ethical issues in nanomedicine. In Nanotechnologies, ethics and politics, ed. H. ten Have, 99–123. Paris: UNESCO.
22. Hett, A., et al. 2004. Nanotechnology – Small matter, many unknowns (Report). Zurich: Swiss Reinsurance Company (“SwissRe”).
23. Hook, C.C. 2004. Nanotechnology. In Encyclopedia of bioethics, vol. 4, 3rd ed, ed. S. Post, 1871–1875. New York: MacMillan.
24. Hook, C.C. 2007. Nanotechnology and the future of medicine. In Nanoscale: Issues and perspectives for the nano century, ed. N.M. de S. Cameron and M.E. Mitchell, 337–357. Hoboken: Wiley-Interscience.
25. Kenny, L. 2007. The risk governance of nanotechnology: Recommendations for managing a global issue. Zurich: Swiss Reinsurance Company (Swiss Re), Centre for Global Dialogue.
26. Lenk, C., and N. Biller-Andorno. 2007. Nanomedicine–emerging or re-emerging ethical issues? A discussion of four ethical themes. Medicine Health Care and Philosophy 10(2): 173–184.
27. Oberdörster, E. 2004. Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environmental Health Perspectives 112(10): 1058–1062.
28. Phoenix, C., and M. Treder. 2003. Applying the precautionary principle to nanotechnology . Brooklyn: Center for Responsible Nanotechnology (CRN). Available online at: http://crnano. org/precautionary.htm.
29. Saunders, P. 2000. Use and abuse of the precautionary principle, Institute of Science in Society (ISIS) submission to US Advisory Committee on International Economic Policy. Available online at: http://www.i-sis.org.uk/prec.php.
30. SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials. Brussels: European Commission. Available online at: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_004c.pdf.
31. Schmid, G., et al. 2006. Nanotechnology: Assessment and perspectives. Berlin: Springer.
32. Stebbing, M. 2009. Avoiding the trust deficit: Public engagement, values, the precautionary principle and the future of nanotechnology. Bioethical Inquiry 6: 37–48.
33. UK-ILGRA (Interdepartmental Liaison Group on Risk Assessment). 2002. The precautionary principe: Policy and application, London. Available online at: http://www.hse.gov.uk/aboutus/meetings/ilgra/pppa.htm.
34. UK-RSRAE (Royal Society and the Royal Academy of Engineering). 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties, summary and recommendations . London: Royal Society. Available online at: http://www.nanotec.org.uk/finalReport.htm.
35. Zhao, X., A. Striolo, and P. Cummings. 2005. C60 binds to and deforms nucleotides. Biophysical Journal 89: 3856–3862.